# RxSight, Inc.: filings

RXST · Nasdaq · CIK 1111485 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rxst.md) · [Financials](/companies/rxst/financials.md) · [Filings](/companies/rxst/filings.md) · [Insiders](/companies/rxst/insiders.md)

## Reports and events: 83 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 184, 144 79, 8-K 48, 3 22, 10-Q 16, SCHEDULE 13G/A 11, SC 13G 8, SC 13G/A 8, S-8 7, SCHEDULE 13G 6, 10-K 5, 424B5 5, CORRESP 5, D/A 5, DEF 14A 5, DEFA14A 5, D 4, ARS 3, EFFECT 3, SD 3, UPLOAD 3, 4/A 2, 8-K/A 2, S-1/A 2, SC 13D/A 2, SC TO-I/A 2, SEC STAFF LETTER 2, 10-K/A 1, 144/A 1, 424B4 1, 8-A12B 1, ARS/A 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, POS AM 1, POSASR 1, PRE 14A 1, S-1 1, S-3 1, S-3ASR 1, SC 13D 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 16:15 ET | [10-Q](/filings/0001193125-26-335153.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335153 |
| 2026-08-05 | 16:15 ET | [8-K](/filings/0001193125-26-335150.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335150 |
| 2026-07-15 | 16:23 ET | [8-K](/filings/0001193125-26-304812.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-304812 |
| 2026-07-06 | 16:15 ET | [8-K](/filings/0001193125-26-296200.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-296200 |
| 2026-07-06 | 16:15 ET | [8-K](/filings/0001193125-26-296201.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-296201 |
| 2026-06-16 | 16:30 ET | [8-K](/filings/0001193125-26-272688.md) | 5.07 Shareholder vote results | 0001193125-26-272688 |
| 2026-05-06 | 16:05 ET | [10-Q](/filings/0001193125-26-208921.md) | Quarterly report, period 2026-03-31 | 0001193125-26-208921 |
| 2026-05-06 | 16:04 ET | [8-K](/filings/0001193125-26-208912.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208912 |
| 2026-04-28 | 16:30 ET | [DEF 14A](/filings/0001193125-26-187240.md) | Proxy statement, period 2026-04-27 | 0001193125-26-187240 |
| 2026-03-19 | 16:06 ET | [8-K/A](/filings/0001193125-26-115965.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-115965 |
| 2026-02-25 | 16:31 ET | [10-K](/filings/0001193125-26-071775.md) | Annual report, period 2025-12-31 | 0001193125-26-071775 |
| 2026-02-25 | 16:05 ET | [8-K](/filings/0001193125-26-071516.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071516 |
| 2026-01-12 | 16:34 ET | [8-K](/filings/0001193125-26-010478.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-010478 |
| 2025-12-23 | 17:21 ET | [8-K](/filings/0001193125-25-331151.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001193125-25-331151 |
| 2025-12-22 | 17:15 ET | [8-K](/filings/0001193125-25-328951.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-328951 |
| 2025-12-19 | 16:15 ET | [8-K](/filings/0001193125-25-326889.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-326889 |
| 2025-11-05 | 16:16 ET | [10-Q](/filings/0001193125-25-266986.md) | Quarterly report, period 2025-09-30 | 0001193125-25-266986 |
| 2025-11-05 | 16:11 ET | [8-K](/filings/0001193125-25-266938.md) | 2.02 Results of operations | 0001193125-25-266938 |
| 2025-08-15 | 16:30 ET | [8-K/A](/filings/0001111485-25-000003.md) | 5.02 Departure or appointment of officers or directors | 0001111485-25-000003 |
| 2025-08-07 | 16:23 ET | [10-Q](/filings/0000950170-25-105070.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105070 |
| 2025-08-07 | 16:10 ET | [8-K](/filings/0000950170-25-105027.md) | 2.02 Results of operations | 0000950170-25-105027 |
| 2025-08-04 | 16:32 ET | [8-K](/filings/0000950170-25-102065.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-102065 |
| 2025-07-08 | 16:10 ET | [8-K](/filings/0000950170-25-094588.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-094588 |
| 2025-06-04 | 16:15 ET | [8-K](/filings/0000950170-25-081636.md) | 5.07 Shareholder vote results | 0000950170-25-081636 |
| 2025-05-07 | 16:15 ET | [10-Q](/filings/0000950170-25-065683.md) | Quarterly report, period 2025-03-31 | 0000950170-25-065683 |
| 2025-05-07 | 16:10 ET | [8-K](/filings/0000950170-25-065655.md) | 2.02 Results of operations | 0000950170-25-065655 |
| 2025-04-21 | 16:30 ET | [DEF 14A](/filings/0000950170-25-056319.md) | Proxy statement, period 2025-04-21 | 0000950170-25-056319 |
| 2025-04-03 | 20:07 ET | [8-K](/filings/0000950170-25-049797.md) | 2.02 Results of operations | 0000950170-25-049797 |
| 2025-02-25 | 16:15 ET | [10-K](/filings/0000950170-25-026681.md) | Annual report, period 2024-12-31 | 0000950170-25-026681 |
| 2025-02-25 | 16:10 ET | [8-K](/filings/0000950170-25-026651.md) | 2.02 Results of operations | 0000950170-25-026651 |
| 2025-01-13 | 06:01 ET | [8-K](/filings/0000950170-25-004478.md) | 2.02 Results of operations | 0000950170-25-004478 |
| 2024-11-07 | 16:15 ET | [10-Q](/filings/0000950170-24-123368.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123368 |
| 2024-11-07 | 16:10 ET | [8-K](/filings/0000950170-24-123322.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123322 |
| 2024-08-05 | 16:15 ET | [10-Q](/filings/0000950170-24-090770.md) | Quarterly report, period 2024-06-30 | 0000950170-24-090770 |
| 2024-08-05 | 16:10 ET | [8-K](/filings/0000950170-24-090744.md) | 2.02 Results of operations | 0000950170-24-090744 |
| 2024-06-06 | 16:15 ET | [8-K](/filings/0000950170-24-069895.md) | 5.07 Shareholder vote results | 0000950170-24-069895 |
| 2024-05-09 | 16:41 ET | [8-K](/filings/0001193125-24-135328.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-135328 |
| 2024-05-06 | 16:15 ET | [10-Q](/filings/0000950170-24-053566.md) | Quarterly report, period 2024-03-31 | 0000950170-24-053566 |
| 2024-05-06 | 16:10 ET | [8-K](/filings/0000950170-24-053553.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053553 |
| 2024-04-25 | 16:30 ET | [DEF 14A](/filings/0000950170-24-048381.md) | Proxy statement, period 2024-04-25 | 0000950170-24-048381 |
| 2024-04-23 | 19:00 ET | [8-K](/filings/0000950170-24-046558.md) | 1.01 Entry into a material agreement | 0000950170-24-046558 |
| 2024-02-28 | 16:10 ET | [10-K](/filings/0000950170-24-022073.md) | Annual report, period 2023-12-31 | 0000950170-24-022073 |
| 2024-02-28 | 16:05 ET | [8-K](/filings/0000950170-24-022053.md) | 2.02 Results of operations | 0000950170-24-022053 |
| 2024-01-08 | 06:01 ET | [8-K](/filings/0000950170-24-002636.md) | 2.02 Results of operations | 0000950170-24-002636 |
| 2023-11-09 | 16:20 ET | [10-Q](/filings/0000950170-23-062099.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062099 |
| 2023-11-09 | 16:10 ET | [8-K](/filings/0000950170-23-062039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062039 |
| 2023-08-18 | 16:18 ET | [SC 13D/A](/filings/0001193125-23-215970.md) | Ownership report, active investor, amended | 0001193125-23-215970 |
| 2023-08-07 | 16:16 ET | [10-Q](/filings/0000950170-23-039081.md) | Quarterly report, period 2023-06-30 | 0000950170-23-039081 |
| 2023-08-07 | 16:11 ET | [8-K](/filings/0000950170-23-039068.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039068 |
| 2023-07-05 | 06:04 ET | [8-K](/filings/0000950170-23-031482.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0000950170-23-031482 |

Page 1 of 2. [Older](/companies/rxst/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.